https://www.zacks.com/stock/news/2207860/danaher-dhr-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2207860
Jan 09, 2024 - Danaher (DHR) concluded the recent trading session at $230.87, signifying a -1.7% move from its prior day's close.
zc:6952626143639166531
0
https://www.zacks.com/stock/news/2211138/danaher-dhr-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2211138
Jan 16, 2024 - Danaher (DHR) reachead $226.75 at the closing of the latest trading day, reflecting a +0.67% change compared to its last close.
zc:-9032999086301096052
0
https://www.zacks.com/stock/news/2211645/why-danaher-dhr-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2211645
Jan 17, 2024 - Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:3323833606436348911
0
https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146
Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
zc:-1303935316860058389
0
https://www.zacks.com/stock/news/2243768/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2243768
Mar 20, 2024 - The latest trading day saw Danaher (DHR) settling at $251.68, representing a -0.81% change from its previous close.
zc:-2426301587910424418
0
https://www.zacks.com/stock/news/2208554/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2208554
Jan 10, 2024 - Danaher (DHR) closed the most recent trading day at $229.64, moving -0.53% from the previous trading session.
zc:7065346973034385044
0
https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212826
Jan 19, 2024 - 3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
zc:-7049465733144145522
0
https://www.zacks.com/stock/news/2213135/can-general-electric-ge-q4-earnings-beat-on-aerospace-boost?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213135
Jan 19, 2024 - Strength in the Aerospace segment and accretive acquisitions are likely to aid General Electric's (GE) fourth-quarter 2023 results.
zc:-2835414412150060116
0
https://www.zacks.com/stock/news/2214255/danaher-dhr-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2214255
Jan 23, 2024 - Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:5480385937956787629
0
https://www.zacks.com/stock/news/2222679/carlisle-csl-q4-earnings-beat-estimates-revenues-decline-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2222679
Feb 07, 2024 - Carlisle (CSL) fourth-quarter 2023 results benefit from higher revenues across the Carlisle Construction Materials segment.
zc:-959306632941684223
0